Sequenom sequenom.com


Public list: Digital Health (6206) Genomics (575)

Sequenom Laboratories, a CAP-accredited and CLIA-certified molecular diagnostics laboratory, has developed a broad range of laboratory tests, with a focus principally on prenatal care. Branded under the names HerediT, HerediT UNIVERSAL, MaterniT GENOME, MaterniT 21 PLUS, NextView, SensiGene and VisibiliT, these molecular genetic laboratory-developed tests provide early patient management information for obstetricians, geneticists, and maternal fetal medicine specialists.

Sequenom Laboratories, a CAP-accredited and CLIA-certified molecular diagnostics laboratory, has developed a broad range of laboratory tests, with a focus principally on prenatal care. Branded under the names HerediT, HerediT UNIVERSAL, MaterniT GENO...Show all

Company (Acquired)

Phone: 877-821-7266

Fax:

3595 John Hopkins Court

San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Sequenom $297M Jul 27, 2016
See all 3 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Sequenom Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Alafi CapitalVenture CapitalSan Francisco, California, United StatesUnattributed VC - VII
Deutsche BankInvestment BankFrankfurt, GermanyUnattributed VC - VII
AlpInvest PartnersPrivate EquityAmsterdam, NetherlandsUnattributed VC - VII, Unattributed VC - VI
AllianzCorporationMunich, GermanyUnattributed VC - VII, Unattributed VC - VI
Comvest PartnersPrivate EquityWest Palm Beach, Florida, United StatesUnattributed VC - VIII
See all 18 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 3 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Reducing sequence read count error in assessment of complex genetic variations Mar 12, 2013 May 29, 2018 Patent
Processes and kits for identifying aneuploidy Dec 20, 2010 Mar 27, 2018 Patent
Methods and compositions for analyzing nucleic acid Mar 01, 2013 Mar 20, 2018 Patent
Reagents for detecting methylated dna Jun 09, 2015 Jan 23, 2018 Patent
Nucleic acid preparation compositions and methods Jan 18, 2017 Dec 26, 2017 Patent
See all 114 patents